The go-to firm for Corporate, Taxation, Negotiation, Visa and Immigration concerns.


Unit 1202 Tycoon Centre Bldg. Pearl Drive
Brgy., San Antonio Ortigas Center,
1611 Pasig City, Philippines


Phone : +632 86953262
  • Blog


MFBR lawyers and associates care!

In light of the constantly changing social and economic landscape in the world due to COVID-19, everyone at Mallari Fiel Brillante Ronquillo has taken steps to make good our steadfast commitment to serve our clients and our communities.

To this end, we designed a new business model incorporating the traditional “brick and mortar” and “virtual” law offices. This new model is to achieve the continuity of rendering our legal and business consultancy services to clients and friends, and the immediate implementation of our crisis management and business transformation activities.

Thus, we’re glad to announce that for every fortnight, half of our team will be physically present at our offices from Monday thru Friday, 8:00am to 3:00pm. Clients and our friends can reach us through our office phones and online platforms (website, emails, Facebook, LinkedIn, Zoom, etc.). And to ensure the health and safety of our staff, they have the option to be housed in the Firm’s private residence or shuttled back and forth using the company’s private vehicle. Safety protocols are also observed at our offices.

Finally, our team has prepared a series of materials around the impact of COVID-19 and related considerations. Please take time to view our sample articles and research published in our website. A complete listing and discussion of these articles are available in our newsletter to be distributed to our esteemed clients.

Should you have questions, please reach out to our Office Manager, Argie Macawile, at +632 86953395, +63977 8502357; or email our Managing Partner, Atty. Rob Mallari, at and


  • Home
  • blog
  • Advisory on Accreditation of Manufacturers of COVID-19 Related Products

Advisory on Accreditation of Manufacturers of COVID-19 Related Products

By: Saliha Naila A. Abdullah

Photo courtesy of: Rappler

On 01 April 2020, the Department of Trade and Industry (DTI) and the Department of Finance (DOF) issued a Joint Memorandum Circular (JMC) No. 2020-02, which authorizes the grant of support, in the form of liberalizing investment incentives, for manufacturers or producers, suppliers of raw materials, manufacturers of packaging materials, and suppliers of raw materials for the packaging of COVID-19-related products. A full text of the Joint Memorandum Circular (JMC) No. 2020-02 may be accessed through:

The liberalization by DTI and DOF on the grant of incentives for the manufacturing of critical COVID-19-related equipment and supplies has the objective of ensuring the availability of these essential goods and minimizing disruptions in the supply chain.

The said joint memorandum circular covers the following covid-19-related products:

(a) Medicine identified as critical and necessity by the Department of Health;

(b) Medical equipment and devices such as test kits, thermometers, thermal scanners, ventilators;

(c) Personal Protective Equipment (PPE);

(d) Surgical equipment and supplies;

(e) Laboratory equipment and its reagents;

(f) Support and maintenance for laboratory and medical equipment;

(g) Medical supplies, tools and consumables, such as alcohol, sanitizers, tissue, hand soap, detergent, sodium hydrochloride, cleaning materials, povidone iodine, and common medicines;

(h) Such other supplies or equipment as may be determined by the Department of Health (DOH) and other relevant government agencies;

Raw materials and packaging materials exclusively used for the production of the above-enumerated products shall also be covered.

Likewise, the qualified enterprises comprising the supply chain to ensure availability of the covered products are as follows:

(a) Manufacturer or producer;

(b) Suppliers of raw materials;

(c) Manufacturer of packaging materials; and

(d) Suppliers of raw materials for the packaging.

The duly-accredited or qualified manufacturers and suppliers of COVID-19-related products are exempt from import duties, taxes and fees such as import processing fees and other fees imposed by the Bureau of Customs (BOC), Food and Drug Administration (FDA), and other relevant agencies.

In line with the above-mentioned mandate, DTI, through the Board of Investments (BOI), is accepting applications for accreditation of manufacturers of COVID-19-related products starting April 15, 2020.

Those enterprises applying for accreditation shall submit a duly filled application Form 1 JMC No. 2020-02, and shall comply with the documentary requirements enumerated in the checklist provided in Form 2 JMC No. 2020-02. The documentary requirements may be submitted through BOI’s email:

In order to avail the exemption from import duties, taxes, and other fees, the accredited enterprise or IPA-registered manufacturer must first secure a Certificate of Authority (CA) from the BOI, provided that such importations are reasonably needed and will be used exclusively in the manufcature of the registered products. A copy of the application for CA or Form 3 JMC No. 2020-02 is downloadable at the official website of BOI. CA Applications may be submitted through email at: Please stay tuned for new issuances and releases from the national government. We will accordingly provide updates as new announcements are given from time to time.

As a rapidly growing, highly qualified group of lawyers, associates, accountants, consultants and paralegals we are dedicated to finding innovative and swift solutions to all our clients' concerns.